Join to View Full Profile
7500 France Ave S.Edina, MN 55435
Phone+1 952-927-6501
Dr. Gearman is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Derek Gearman, MD is a specialist in Urology based in Edina, MN and is currently working for MN Urology.
He received his medical degree in 2014 from the University of South Dakota, Sanford School of Medicine and completed his residency in Urology at the Mayo Clinic College of Medicine and Science in Rochester from 2015 - 2019.
Dr. Gearman has notable experience in HoLEP, MIS surgery, kidney stone diseae. He has authored several publications in reputable journals that focused on diverse urological topics such as prostate cancer outcomes, and the effects of anticoagulation on bleeding-related complications post-ureteroscopy. These works have been frequently cited by other publications.
Education & Training
Mayo Clinic College of Medicine and Science (Rochester)Residency, Urology, 2015 - 2019
University of South Dakota, Sanford School of MedicineClass of 2014, MD
Certifications & Licensure
IA State Medical License 2023 - 2025
MN State Medical License 2015 - 2025
ND State Medical License 2023 - 2025
SD State Medical License Active through 2025
WI State Medical License 2023 - 2025
AZ State Medical License 2020 - 2021
American Board of Urology Urology
Publications & Presentations
PubMed
- 4 citationsRobot-Assisted Laparoscopic Urachal Excision Using Hidden Incision Endoscopic Surgery Technique in Pediatric PatientsTijani Osumah, Candace F. Granberg, Mohit Butaney, Derek J. Gearman, Mohamed E. Ahmed
Journal of Endourology. 2021-06-17 - 29 citationsComparison of Pathological and Oncologic Outcomes of Favorable Risk Gleason Score 3 + 4 and Low Risk Gleason Score 6 Prostate Cancer: Considerations for Active Surveil...Derek J. Gearman, Alessandro Morlacco, John C. Cheville, Laureano J. Rangel, R. Jeffrey Karnes
The Journal of Urology. 2018-05-01 - 48 citationsAdverse Disease Features in Gleason Score 3 + 4 “Favorable Intermediate-Risk” Prostate Cancer: Implications for Active SurveillanceAlessandro Morlacco, John C. Cheville, Laureano J. Rangel, Derek J. Gearman, R. Jeffrey Karnes
European Urology. 2017-09-01
Press Mentions
Is Favorable-Risk GG2 Prostate Ca Suitable for Active Surveillance?January 18th, 2018
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
